Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on genetic health. Browse all genetic health education

Human papillomavirus (HPV) is extremely common — most sexually active people encounter it at some point — yet the vast majority clear the virus without ever knowing they had it. A minority develop persistent infections that can lead to warts or, in some HPV types, cell changes linked to cancer. Why the difference? Part of the answer is genetic: how your immune system recognizes and clears the virus varies from person to person.

This article covers the genes researchers connect to HPV clearance and susceptibility, and, just as importantly, the proven, non-genetic ways to protect yourself — which matter far more than any single variant.

How the immune system handles HPV

When HPV infects the cells of the skin or mucous membranes, the immune system's job is to recognize infected cells and clear them. This depends heavily on the human leukocyte antigen (HLA) system — a set of genes that present viral fragments to immune cells so they can mount a response. Differences in HLA genes influence how efficiently a person's immune system spots and clears specific HPV types, which helps explain why some people clear the virus quickly and others harbor persistent infections.

Genes linked to HPV clearance and risk

The best-established genetic associations sit in the HLA region. Variants in HLA-DRB1 and HLA-DQB1 have been repeatedly associated with either faster clearance or higher risk of persistent HPV infection and cervical abnormalities. Separately, the TMC6 and TMC8 genes (also called EVER1 and EVER2) are famous in a rare inherited condition, epidermodysplasia verruciformis, in which people are highly susceptible to certain HPV types — evidence that specific genes shape antiviral defense against papillomaviruses. For the general population, these associations shift probability at the margins; they do not determine who gets HPV.

What the research shows

Large studies of cervical HPV have consistently linked HLA class II variation to clearance and persistence, and functional work supports the idea that antigen presentation is central to the response. The TMC6/TMC8 story demonstrates a clear gene-to-susceptibility link in a rare setting. Still, HPV outcomes are dominated by factors you can act on: vaccination status, smoking, immune health, and screening. Genetics is a small piece of a much larger, more modifiable picture.

Protection methods that actually work

Regardless of genetics, the evidence-based protections are well established. HPV vaccination is highly effective at preventing infection with the highest-risk types and is recommended for the age ranges specified by current public-health guidance. Routine cervical screening (Pap and HPV testing) catches cell changes early, when they are most manageable. Condoms reduce but do not eliminate transmission risk. Not smoking supports immune clearance. These steps protect everyone, whatever their HLA type.

Where genetic insight fits

Genetic variation can help explain why immune responses to viruses differ, but it is not a screening tool for HPV and cannot tell you whether you carry the virus or will clear it. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in immune-related pathways. Think of that as background on how your immune biology is tuned — useful context for a conversation with a provider, never a replacement for vaccination, screening, or medical care. Genetics is a guide, not a guarantee.

Frequently Asked Questions About HPV and Genetics

Can genetics tell me if I will get HPV or clear it?

No. Genetic variation in HLA genes like HLA-DRB1 and HLA-DQB1 is associated with faster or slower HPV clearance across populations, but it cannot predict your individual outcome or detect infection. Whether you contract or clear HPV depends far more on vaccination, immune health, smoking, and exposure than on any single variant.

Which genes are linked to HPV susceptibility?

The strongest associations are in the HLA region — particularly HLA-DRB1 and HLA-DQB1 — which governs how the immune system presents viral fragments. The TMC6 and TMC8 genes (EVER1/EVER2) drive extreme HPV susceptibility in a rare inherited condition. These shape antiviral defense, but for most people the effect on everyday risk is modest.

Does the HPV vaccine work regardless of my genetics?

Yes. HPV vaccination is highly effective at preventing infection with the highest-risk HPV types across the population, independent of your HLA genotype. It is one of the most reliable protection methods available. Current public-health guidance specifies the recommended age ranges; a provider can advise whether it is appropriate for you.

What is the best way to protect against HPV?

The most effective steps are HPV vaccination, routine cervical screening (Pap and HPV testing) to catch cell changes early, consistent condom use to reduce transmission, and not smoking to support immune clearance. These evidence-based measures protect everyone regardless of genetic background and matter far more than any inherited variant.

Interested in how your immune-related pathways are set up? Take the Precision Peptide Genetic Test to see how your DNA shapes the pathways discussed here — and bring that context to your provider.

This article is part of the PlexusDx Education Hub. Browse all genetic health education

Compliance note: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not diagnose, treat, cure, or prevent any disease, and it does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your care.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.